AU2019279208B2 - Composite material and bioimplant - Google Patents

Composite material and bioimplant Download PDF

Info

Publication number
AU2019279208B2
AU2019279208B2 AU2019279208A AU2019279208A AU2019279208B2 AU 2019279208 B2 AU2019279208 B2 AU 2019279208B2 AU 2019279208 A AU2019279208 A AU 2019279208A AU 2019279208 A AU2019279208 A AU 2019279208A AU 2019279208 B2 AU2019279208 B2 AU 2019279208B2
Authority
AU
Australia
Prior art keywords
composite material
phase
region
titanium
material according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2019279208A
Other versions
AU2019279208A1 (en
Inventor
Masayuki Kyomoto
Kenichi SAIGA
Kenichi Watanabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyocera Corp
Original Assignee
Kyocera Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyocera Corp filed Critical Kyocera Corp
Publication of AU2019279208A1 publication Critical patent/AU2019279208A1/en
Application granted granted Critical
Publication of AU2019279208B2 publication Critical patent/AU2019279208B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/42Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having an inorganic matrix
    • A61L27/427Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having an inorganic matrix of other specific inorganic materials not covered by A61L27/422 or A61L27/425
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61CDENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
    • A61C8/00Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools
    • A61C8/0012Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools characterised by the material or composition, e.g. ceramics, surface layer, metal alloy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61CDENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
    • A61C13/00Dental prostheses; Making same
    • A61C13/08Artificial teeth; Making same
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61CDENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
    • A61C8/00Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools
    • A61C8/0012Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools characterised by the material or composition, e.g. ceramics, surface layer, metal alloy
    • A61C8/0013Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools characterised by the material or composition, e.g. ceramics, surface layer, metal alloy with a surface layer, coating
    • A61C8/0015Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools characterised by the material or composition, e.g. ceramics, surface layer, metal alloy with a surface layer, coating being a conversion layer, e.g. oxide layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • A61F2/34Acetabular cups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • A61F2/36Femoral heads ; Femoral endoprostheses
    • A61F2/3662Femoral shafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/50Preparations specially adapted for dental root treatment
    • A61K6/58Preparations specially adapted for dental root treatment specially adapted for dental implants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/80Preparations for artificial teeth, for filling teeth or for capping teeth
    • A61K6/84Preparations for artificial teeth, for filling teeth or for capping teeth comprising metals or alloys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • A61L27/04Metals or alloys
    • A61L27/06Titanium or titanium alloys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61CDENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
    • A61C2201/00Material properties
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • A61F2/36Femoral heads ; Femoral endoprostheses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005The prosthesis being constructed from a particular material
    • A61F2310/00011Metals or alloys
    • A61F2310/00023Titanium or titanium-based alloys, e.g. Ti-Ni alloys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/18Modification of implant surfaces in order to improve biocompatibility, cell growth, fixation of biomolecules, e.g. plasma treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/12Materials or treatment for tissue regeneration for dental implants or prostheses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/24Materials or treatment for tissue regeneration for joint reconstruction

Landscapes

  • Health & Medical Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Dentistry (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ceramic Engineering (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Plastic & Reconstructive Surgery (AREA)
  • Composite Materials (AREA)
  • Materials Engineering (AREA)
  • Materials For Medical Uses (AREA)
  • Dental Preparations (AREA)
  • Physical Vapour Deposition (AREA)
  • Prostheses (AREA)
  • Dental Prosthetics (AREA)

Abstract

A composite material according to one embodiment has a crystal phase of a titanium fluoride and a metal crystal phase of titanium. The crystal phase of titanium fluoride is present in a first region located away from the surface in the depth direction.

Description

DESCRIPTION COMPOSITE MATERIAL AND BIOIMPLANT TECHNICAL FIELD
[0001]
The present disclosure relates to a composite
material and a bioimplant.
BACKGROUND ART
[0002]
A metal material whose surface is subjected to
fluorine ion implantation has been known (for example,
refer to Patent Document 1 and Non-patent Document 1).
RELATED ART DOCUMENTS PATENT DOCUMENT
[0003]
Patent Document 1: Japanese Patent No. 4568396
NON-PATENT DOCUMENT
[00041
Non-patent Document 1: M. Yoshinari, Y. Oda, T.
Kato, K. Okuda, "Influence of surface modifications to
titanium on antibacterial activity in vitro,"
Biomaterials, 2001, 22, p. 2043-2048
SUMMARY
[0005]
A composite material in one of embodiments includes
a crystal phase of titanium fluoride and a metal crystal phase of titanium. The crystal phase of the titanium fluoride is present in a first region located away from a surface in a depth direction.
[0006]
A bioimplant in one of embodiments includes the
composite material in one of the embodiments.
BRIEF DESCRIPTION OF THE DRAWINGS
[0007]
FIG. 1 is a schematic diagram illustrating a
composite material in one of embodiments;
FIG. 2 is one embodiment of a bioimplant in one of
embodiments;
FIG. 3 is a graph illustrating fluorine
concentration measurement results in Examples; and
FIG. 4 is a graph illustrating hardness measurement
results in Examples and Comparative Example.
EMBODIMENTS
[00081
<Composite Material>
A composite material in one of embodiments is
described in detail below with reference to the drawings.
For the sake of description, the drawings referred to in
the following illustrate, in simplified form, only main
configurations necessary for describing the embodiments.
The composite material in the embodiment is therefore
capable of including any arbitrary configuration not
illustrated in the drawings referred to. Dimensions of the configurations in the drawings faithfully represent neither dimensions of actual configurations nor dimensional ratios of these configurations. These points are also true for a bioimplant described later.
[00091
FIG. 1 is a schematic diagram illustrating the
composite material in the embodiment. A cross section of
a part including a surface of the composite material is
enlargedly illustrated in FIG. 1.
[0010]
The composite material 1 includes titanium (Ti) and
fluorine (F) and includes a crystal phase 2 of titanium
fluoride (hereinafter also referred to as "the crystal
phase 2") and a metal crystal phase 3 of titanium
(hereinafter also referred to as "the metal crystal phase
3"). The titanium fluoride that is a compound of
titanium and fluorine is present in a crystal state in
the crystal phase 2. The titanium is present in a state
of crystal formed by metallic bonding in the metal
crystal phase 3.
[0011]
The composite material 1 includes fluorine and the
crystal phase 2 as described above. Therefore, it
becomes possible to offer antibacterial activity owing to
the fluorine. Because the composite material 1 has high
hardness, it becomes possible to offer excellent wear
resistance or the like. The reason why the composite material 1 has the high hardness seems to be as follows.
[0012]
The bonding between titanium and fluorine in the
titanium fluoride is covalent bonding. The crystal phase
2 therefore serves as an obstacle to dislocation for
moving the metal crystal phase 3. Accordingly, if the
composite material 1 includes the crystal phase 2, an
amount of energy necessary for dislocation movement
becomes larger, thus leading to enhanced hardness of the
composite material 1. A ratio of the crystal phase 2
tends to increase with increasing a fluorine
concentration in the composite material 1.
[00131
Examples of the titanium fluoride include TiF
(titanium monofluoride), TiF2 (titanium difluoride), TiF3
(titanium trifluoride), TiF4 (titanium tetrafluoride),
TiOF (titanium oxyfluoride), TiOF2 (titanium
oxydifluoride) and F-TiO2 (fluorine doped titanium oxide).
The titanium fluoride may be TiOF2. The crystal phase 2
may include Ti-F-Ti bonding (covalent bonding).
[0014]
As a method for measuring a crystal structure,
there are, for example, Transmission Electron Microscope
(hereinafter also referred to as "TEM"), X-ray
Diffraction (hereinafter also referred to as "XRD") and
X-ray Photoelectron Spectroscopy (hereinafter also
referred to as "XPS").
[0015]
The composite material 1 may include a region
(first region) 12 which includes a surface 11 of the
composite material 1 and has a predetermined thickness in
a depth direction from the surface 11. The first region
12 is a composite phase of titanium and fluorine. A
fluorine concentration of the first region 12 may be 1
ppm or more.
[00161
A thickness T of the first region 12 is, for
example, 30-800 nm. If a numerical value range is
indicated using "-", numerical values of a lower limit
and an upper limit are included unless otherwise noted.
For example, a numerical value range of 30-800 nm denotes
that the lower limit is 30 nm or more and the upper limit
is 800 nm or less.
[0017]
The crystal phase 2 may be located in the first
region 12. If satisfying this configuration, the crystal
phase 2 is located in the vicinity of the surface 11.
This contributes to enhancing antibacterial activity
owing to the fluorine in the titanium fluoride and also
increasing hardness of the surface 11 and neighborhoods
thereof.
[0018]
The crystal phase 2 may be located in a region with
a depth range of 20-200 nm from the surface 11. The depth may be determined on the basis of the surface 11.
[0019]
The metal crystal phase 3 may include a first phase
31 containing fluorine (fluorine-containing phase). In
other words, the metal crystal phase 3 may include the
first phase 31 including fluorine in a crystal lattice of
titanium. The fluorine may be introduced as an
interstitial element into the crystal lattice of titanium
in the first phase 31. If the metal crystal phase 3
includes the first phase 31, the hardness of the
composite material 1 can be further enhanced. The reason
for this seems to be as follows.
[00201
A fluorine atom enters a space in the crystal
lattice of titanium formed by metallic bonding in the
first phase 31. The crystal of titanium is therefore
subjected to lattice distortion according to a size of
the fluorine atom thus entered. Deformation of the
crystal lattice of titanium is caused by dislocation
movement that is a defect of the crystal lattice. When
the titanium crystal lattice strain occurred by fluorine
doping, dislocation mobility is decreased and hardness of
the composite material 1 is increased. Hence, with the
metal crystal phase 3 including the first phase 31, the
first phase 31 besides the crystal phase 2 also
contributes to the hardness of the composite material 1,
thereby further enhancing the hardness of the composite material 1. A ratio of the first phase 31 tends to increase with decreasing the fluorine concentration in the composite material 1.
[0021]
The first phase 31 may be located in the first
region 12. If satisfying this configuration, the
hardness of the surface 11 and neighborhoods thereof can
be enhanced because the first phase 31 is located in the
vicinity of the surface 11. The first region 12 in which
the first phase 31 is located is identical with the first
region 12 in which the crystal phase 2 is located. This
is also true for the first region 12 in which a second
phase 32 described later is located, the first region 12
at which a maximum value of fluorine concentration is
located, and the first region 12 at which a maximum value
of hardness is located. That is, the first regions 12 in
the description of the individual configurations are
identical to each other.
[0022]
The metal crystal phase 3 may further include a
second phase 32 including no fluorine (non-fluorine
containing phase) located more inside than the first
phase 31. If satisfying this configuration, a region
including the first phase 31, which is located closer to
the surface 11 than the second phase 32, is less
susceptible to damage. Specifically, because the second
phase 32 includes no fluorine, the second phase 32 has higher toughness than the first phase 31. Accordingly, upon impact on the surface 11, the impact can be relaxed by the second phase 32 having relatively high toughness.
Consequently, the region including the first phase 31,
which is located closer to the surface 11 than the second
phase 32, becomes less susceptible to damage.
[0023]
The phrase that "the second phase 32 is located
more inside than the first phase 31" denotes that the
second phase 32 is located more away from the surface 11
than the first phase 31. The term "inside" denotes being
located inside the composite material 1 relative to the
surface 11. In other words, the term "inside" denotes a
depth increasing direction in the composite material 1.
The term "including no fluorine" denotes a state of
including substantially no fluorine and being
substantially free from influence of fluorine.
Specifically, if the fluorine concentration is less than
1 ppm, a determination may be made that it is free from
fluorine.
[0024]
The second phase 32 may be located more inside than
the first region 12. If satisfying this configuration,
the first region 12 located closer to the surface 11 than
the second phase 32 is less susceptible to damage because
the second phase 32 has relatively high toughness.
[00251
The composite material 1 may further include a
region (second region) 13 located more inside than the
first region 12. The second region may the region
including titanium but not including fluorine. The
second phase 32 may be located in the second region. The
second region 13 may be in contact with the first region
12. That is, the first region 12 and the second region
13 may be continuous regions in the composite material 1.
[0026]
The metal crystal phase 3 may include, for example,
a titanium-based metal. Examples of the titanium-based
metal include pure titanium and titanium alloys.
Examples of the pure titanium include industrial pure
titanium, such as C.P. two types titanium whose base
phase is titanium. The titanium alloys are alloys whose
base phase is titanium. Examples thereof include Ti
6Al(aluminum)-4V(vanadium), Ti-15Mo(molybdenum)
5Zr(zirconium)-3Al, Ti-Nb(niobium), Ti-6Al-7Nb, Ti-6Al
2Nb-lTa(tantalum), Ti-30Zr-Mo, Ni(nickel)-Ti, Ti-3Al-2.5V,
Ti-l0V-2Fe(iron)-3Al and Ti-15V-3Cr(chrome)-3Al-3Sn(tin).
[0027)
The composite material 1 may further include an
amorphous phase 4 including titanium and fluorine. If
satisfying this configuration, the composite material 1
is less susceptible to damage because the amorphous phase
4 has high toughness.
[0028]
The amorphous phase 4 may be located in the first
region 12. If satisfying this configuration, the first
region 12 becomes less susceptible to damage because the
amorphous phase 4 has the high toughness.
[0029]
The composite material 1 may further include a
mixed phase 5 including the amorphous phase 4, the
crystal phase 2 and the metal crystal phase 3 (the first
phase 31). The mixed phase 5 is located in the first
region 12 in one of the embodiments. The amorphous
phases 4, the crystal phases 2 and the metal crystal
phases 3 are mixed in the mixed phase 5. Although
material characteristics of the individual phases are
different from each other, the material characteristics
of the composite material 1 in the first region 12 become
characteristics according to a ratio of the individual
phases. Specifically, their respective material
characteristics become those obtained by averaging the
material characteristics of the included individual
phases, or alternatively, become characteristics close to
average characteristics. That is, the composite material
1 includes the individual phases as the mixed phase 5,
making it possible to reduce parts different in material
characteristics in the first region. With the composite
material 1 including the mixed phase 5, it is possible to
reduce the probability that a material partially
separates from the first region 12. This leads to improved stability of the composite material 1.
[0030]
The fluorine concentration in the composite
material 1 may reach a maximum value at a portion located
more inside than the surface 11 (refer to FIG. 3). If
satisfying this configuration, in a situation where the
surface 11 is newly exposed due to wear or the like, the
surface 11 having a relatively high fluorine
concentration tends to be exposed. This facilitates to
offer antibacterial activity over a long period of time.
[0031]
The fluorine concentration may increase to a
maximum value as going from the surface 11 toward the
inside (refer to FIG. 3). In other words, the fluorine
concentration may increase to the maximum value with
increasing depth. If satisfying this configuration, in
the situation where the surface 11 is newly exposed due
to wear or the like, the surface 11 having the relatively
high fluorine concentration tends to be exposed. This
facilitates to offer antibacterial activity over the long
period of time. A period of time during which the
composite material 1 offers the antibacterial activity
can be controlled by controlling a distribution of the
fluorine concentration.
[00321
The maximum value of the fluorine concentration may
be located in the first region 12. If satisfying this configuration, the maximum value of the fluorine concentration is located in the vicinity of the surface
11, thus enhancing the antibacterial activity.
[0033]
The maximum value of the fluorine concentration may
be located closer to a side of the surface 11 than a
midportion 12a in a thickness direction A of the first
region 12 (refer to FIGs. 1 and 3). If satisfying this
configuration, the maximum value of the fluorine
concentration is located in the vicinity of the surface
11, thus leading to the enhanced antibacterial activity.
[00341
A concentration in the fluorine concentration is an
atomic concentration. The fluorine concentration in one
of the embodiments is the number of fluorine atoms per
unit volume relative to a sum of an ideal atomic number
of titanium atoms per unit volume and the number of
fluorine atoms. Examples of a method for measuring a
fluorine concentration include Secondary Ion Mass
Spectrometry (hereinafter also referred to as "SIMS") and
XPS. The SIMS is suitable in cases where the fluorine
concentration is relatively low. The XPS is suitable in
cases where the fluorine concentration is relatively high.
[0035]
The maximum value of fluorine concentration is, for
example, 10-80 atom%. A fluorine concentration in a
region from the surface 11 to less than 5 nm depth is, for example, 0.5-20 atom%. A fluorine concentration in a region with a depth range of not less than 5 nm but less than 20 nm is, for example, 2-30 atom%. A fluorine concentration in a region with a depth range of not less than 20 nm but less than 50 nm is, for example, 5-80 atom%. A fluorine concentration in a region with a depth range of not less than 50 nm but not more than 100 nm is, for example, 2-80 atom%.
[0036]
The hardness of the composite material 1 may reach
a maximum value at a portion located more inside than the
surface 11 (refer to FIG. 4). If satisfying this
configuration, in the situation where the surface 11 is
newly exposed due to wear or the like, the surface 11
having relatively high hardness tends to be exposed.
This enhances the possibility that the surface 11 has the
high hardness over a long period of time. The surface 11
in the description of the hardness is identical to the
surface 11 in the above description of the fluorine
concentration.
[0037]
The hardness may increase to a maximum value as
going from the surface 11 toward the inside (refer to FIG.
4). In other words, the hardness may increase to the
maximum value with increasing depth. If satisfying this
configuration, in the situation where the surface 11 is
newly exposed due to wear or the like, the surface 11 having the relatively high hardness tends to be exposed.
This leads to the high hardness of the surface 11 over a
long period of time.
[00381
Alternatively, the hardness may increase to a
maximum value as going from the surface 11 toward the
inside, and thereafter may decrease as going more inside
(refer to FIG. 4). In other words, the composite
material 1 may be configured so that the hardness changes
moderately in the inside. With this configuration, a
local stress is less likely to occur than a configuration
that hardness inside the composite material 1 changes
sharply. The first region 12 is therefore less likely to
separate.
[00391
The maximum value of the hardness may be located in
the first region 12. If satisfying this configuration,
the maximum value of the hardness is located in the
vicinity of the surface 11, and it is therefore possible
to increase the hardness of the surface 11 and
neighborhoods thereof.
[0040]
The maximum value of the hardness may be located
closer to a side of the surface 11 than the midportion
12a in the thickness direction A of the first region 12
(refer to FIGs. 1 and 4). If satisfying this
configuration, the maximum value of the hardness is located in the vicinity of the surface 11, and it is therefore possible to increase the hardness of the surface 11 and neighborhoods thereof.
[0041]
The maximum value of the hardness may be located
closer to the surface 11 than the maximum value of
fluorine concentration (refer to FIGs. 3 and 4). If
satisfying this configuration, hardness of a portion
located closer to the surface 11 than a portion having
the maximum value of fluorine concentration becomes
relatively high. A portion located closer to the surface
11 than the portion having the maximum value of fluorine
concentration is less susceptible to damage due to wear
or the like, thereby offering antibacterial activity over
a long period of time.
[00421
The hardness is, for example, 3-10 GPa. The
maximum value of the hardness is, for example, 5-10 GPa.
The hardness is indentation hardness and denotes
deformation resistance of the surface 11 if subjected to
deformation. The hardness is calculated from an
indentation depth when an indenter is pressed against the
surface 11, and power necessary therefor. As a specific
method for measuring hardness, there is, for example,
nanoindentation method (according to ISO 14577).
[0043]
The composite material 1 may further include an oxide film (not illustrated) located on an outermost surface. In this case, the surface 11 of the composite material 1 is composed of a surface of the oxide film. A thickness of the oxide film is, for example, 2-5 nm.
Examples of composition of the oxide film include TiO2
(titanium dioxide). The oxide film may include fluorine.
For example, the oxide film is formed by oxidation
treatment. Examples of oxidation treatment include
natural oxidation, heat treatment, oxygen plasma
treatment, immersion into an oxidation solution, and
anodic oxidation.
[0044]
A content of titanium may be larger than a content
of fluorine in the composite material 1. The composite
material 1 may include titanium as a main composition.
The main composition is a composition whose mass ratio is
highest in the composite material 1.
[0045]
<Method for Manufacturing Composite Material>
A method for manufacturing a composite material in
one of embodiments is described in detail below by
exemplifying the case of obtaining the above composite
material 1.
[0046]
Firstly, titanium-based metal is prepared. The
titanium-based metal may be washed if necessary. Washing
may be carried out using, for example, an organic solvent.
Examples of the organic solvent include ethanol and
acetone. The organic solvents exemplified here may be
used by being mixed together. The washing may be carried
out while applying ultrasonic waves. The titanium-based
metal after being washed may be subjected to, for example,
vacuum drying in a desiccator.
[0047]
Subsequently, fluorine ions are implanted into a
surface of the titanium-based metal, thereby obtaining
the composite material 1. Examples of implantation
conditions of fluorine ion include the following
conditions.
Implantation energy: more than 30 keV but not more
than 80 keV
Implantation dose: 1x1016 - 5x1017 atom/cm 2
[00481
The obtained composite material 1 may be washed if
necessary. Conditions of the washing may be identical to
those exemplified in the above titanium-based metal. The
composite material 1 after being washed may be subjected
to, for example, vacuum drying in the desiccator.
[0049]
Although the above embodiment has illustrated and
described the case of obtaining the composite material 1
by the fluorine ion implantation, the method for
manufacturing the composite material 1 is not limited
thereto. Other methods other than the fluorine ion implantation are employable as long as the composite material 1 is obtainable.
[0050]
<Bioimplant>
A bioimplant in one of embodiments is described in
detail below with reference to the drawings. As an
example of the bioimplant, a dental implant is described
in the present embodiment.
[0051]
FIG. 2 is a schematic diagram illustrating an
appearance of the dental implant in the embodiment.
[0052]
The dental implant 100 includes a fixture 101, an
abutment 102 attached to an end portion of the fixture
101, and an artificial tooth 103 attached to the fixture
101 with the abutment 102 interposed therebetween.
[0053]
The fixture 101, the abutment 102 and the
artificial tooth 103 in the dental implant 100 include
the composite material 1. Because the composite material
1 has the antimicrobial activity and high hardness as
described earlier, the dental implant 100 is capable of
reducing growth of bacteria and offering excellent
durability against brushing, repetitive use, washing or
the like.
[0054]
For example, the fixture 101, the abutment 102 and the artificial tooth 103 may be individually formed only by the composite material 1. Alternatively, a part of these may be composed by the composite material 1, and the rest may be composed by a material other than the composite material 1. Still alternatively, at least one of the fixture 101, the abutment 102 and the artificial tooth 103 may include the composite material 1, and the rest may include a material other than the composite material 1. This configuration contributes to reducing the growth of bacteria in the surface of the implant.
For example, a reduction in growth of anaerobic bacteria
can be expected because the fixture 101 and the abutment
102 are used in an oxygen-deficient atmosphere. For
example, a reduction in growth of facultative anaerobic
bacteria and aerobic bacteria can be expected because the
artificial tooth 103 is exposed in a buccal cavity and
exposed to air. Thus, the composite material 1 may
suitably be applied to the fixture 101, the abutment 102
and the artificial tooth 103 according to the kind of
bacteria whose growth needs to be reduced, and necessary
antimicrobial performance.
[0055)
The first region 12 in the composite material 1 may
be located at, for example, a portion of the dental
implant 100 with which bacteria is likely to contact and
which is likely to wear out. For example, the dental
implant 100 may be configured so that the first region 12 is located at individual surfaces of the fixture 101, the abutment 102 and the artificial tooth 103. Alternatively, the dental implant 100 may be configured so that the first region 12 is located at individual connection parts of the fixture 101, the abutment 102 and the artificial tooth 103. This is also true for other bioimplant described later and members other than the bioimplant.
[00561
While the embodiments in the present disclosure has
been illustrated and described above, it is to be
understood that the present disclosure is not limited to
the foregoing embodiments and may be made into any
arbitrary ones insofar as they do not depart from the
spirit and scope of the present disclosure.
[0057]
For example, even though the case where the
bioimplant is the dental implant has been described as an
example in the above embodiments, the bioimplant is not
limited thereto. For example, the bioimplant may be an
implant for biocompatible metal, such as titanium.
Examples of other bioimplant include artificial joints
such as femoral stems and acetabulum shells, and spine
surgery implants such as spine fixation instrumentation.
[0058]
Even though the case where the composite material 1
is intended for the bioimplant has been described as an
example in the above embodiments, the composite material
1 is not limited to the purpose of the bioimplant. That
is, the composite material 1 may be used as a material of
a member for which antibacterial activity and high
hardness are necessary. Examples of other members
include orthodontic wire, surgical instrument, hypodermic
needles, glasses frames, tableware, food factory lines,
water bottle faucets, kitchen knives, toilets, Washlet
(registered trademark), taps, and water and sewage pipes.
[00591
The present disclosure is described in detail below
by giving examples. However, the present disclosure is
not limited to the following examples.
EXAMPLES
[0060]
[Examples 1 and 2]
<Composite Material Manufacturing>
Firstly, the following specimen was prepared.
Specimen: lmm thick pure titanium composed of C. P.
two types titanium
[00611
The above specimen was formed in a disk shape
having a diameter of 14 mm and a thickness of 1 mm. This
was washed with ethanol and acetone while applying
ultrasonic waves, and was then subjected to vacuum drying
in a desiccator. Thereafter, fluorine ions were
implanted into a surface of the specimen under different
conditions, thereby obtaining a composite material 1 of
Example 1 and that of Example 2.
[0062]
Implantation conditions of the fluorine ions were
as follows.
(Example 1)
Implantation energy: 40 keV
Implantation dose: 5x1017 atom/cm 2
(Example 2)
Implantation energy: 40 keV
Implantation dose: 5x10 1 6 atom/cm 2
[0063]
Evaluations were made of the obtained composite
materials 1 after being washed with ethanol and acetone
while applying ultrasonic waves, followed by vacuum
drying in the desiccator.
[00641
[Comparative Example 1]
Comparative Example 1 was the same specimen as
Examples 1 and 2, except that no fluorine ions were
implanted therein.
[0065]
<Evaluation>
Measurements were made of fluorine concentration,
hardness and crystal structure of the composite materials
1 of Examples 1 and 2. Measurement was also made of
antimicrobial activity of the composite material 1 of
Example 1. Measurements were made of hardness and antimicrobial activity of Comparative Example 1.
[0066]
FIG. 3 is a graph illustrating measurement results
of fluorine concentration in Examples 1 and 2.
[0067]
(Fluorine Concentration)
The fluorine concentrations of Examples 1 and 2
were measured by the XPS and the SIMS. Specifically, a
region where the fluorine concentration is relatively
high and goes beyond a measurement range of the SIMS was
subjected to fluorine concentration calculation by the
XPS, and regions other than the above region was
subjected to fluorine concentration calculation by the
SIMS. Specifically, a range where the fluorine
concentration was less than 10 atom% was subjected to
fluorine concentration calculation by the SIMS. A range
where the fluorine concentration was 10 atom% or more was
subjected to fluorine concentration calculation by the
XPS. The measurement by the XPS was carried out at a
depth of 0-200 nm, and the measurement by the SIMS was
carried out at a depth of 0-900 nm. FIG. 3 illustrates
only the measurement results at the depth of 0-200 nm.
In FIG. 3, the depth 0 nm indicates the surface 11 of the
composite material 1. This is also true for FIG. 4
described later. Measurement conditions for the XPS and
SIMS are as follows.
[0068]
(Measurement Conditions for the XPS)
Analyzer: X-ray Photoelectron Spectroscopy Analyzer
"PHI Quantera II" manufactured by ULVAC-PHI Corporation
X-ray source: Monochrome AlKax
Sputtering ion: Ar+
Accelerating voltage: 4 kV
[0069]
(Measurement Conditions for the SIMS)
Analyzer: Secondary Ion Mass Analyzer "D-SIMS 6650"
manufactured by ULVAC-PHI Corporation
Primary ion species: Cs+
Secondary ion polarity: Negative
Accelerating voltage: 2 kV
Beam current: 25 nA
Charge compensation: None
Raster size: 400 pm
[0070]
Measurement results showed the following. That is,
a maximum value of fluorine concentration was located at
a depth of 90 nm in Example 1. The maximum value of the
fluorine concentration in Example 1 was 63 atom%. A
maximum value of fluorine concentration was located at a
depth of 46 nm in Example 2. The maximum value of the
fluorine concentration in Example 2 was 11 atom%.
[0071]
A region from the depth 0 nm (the surface 11) to a
depth at which the fluorine concentration reached 1 ppm was a region 12, and a thickness T thereof was measured.
The measurement results are as follows.
Thickness T of the first region)
Example 1: 740 nm
Example 2: 390 nm
[0072]
FIG. 4 is a graph illustrating measurement results
of hardness in Examples 1 and 2 and Comparative Example 1.
[0073]
(Hardness)
The hardness was measured by nanoindentation method
(according to ISO 14577). The measurement was carried
out at a depth of 0-1000 nm. FIG. 4 illustrates only the
measurement results at the depth of 0-500 nm.
[0074]
Measurement conditions of hardness are as follows:
Measuring device: "Nanoindenter XP" manufactured by
MTS Systems Corporation
Measuring mode: Continuous stiffness measurement
Indentation depth: Maximum value 1000 nm
Hardness unit: Vickers hardness
[0075]
Measurement results showed the following. That is,
a maximum value of hardness was located at a depth of 70
nm in Example 1, and the maximum value of hardness in
Example 1 was 5 GPa. A maximum value of hardness was
located at a depth of 20 nm in Example 2, and the maximum value of hardness in Example 2 was 7 GPa.
[0076]
(Crystal Structure)
Crystal structure was evaluated by the TEM, XRD and
XPS. In individual measurements of the TEX, XRD and XPS,
the first region 12 was determined from the thickness T
of the first region 12, and a region located more inside
than the first region 12 was a second region.
[0077]
Measurement conditions for the TEM are as follows.
Analyzer: Transmission electron microscope "Talos
F200X" manufactured by FEI Corporation
Accelerating voltage: 200 kV
Beam current value: 150 pA
Measurement location: A cross section of the
composite material 1 being cut out in a thickness
direction
[0078]
Measurement conditions for the XRD are as follows.
Analyzer: "X'Pert PRO-MRD" manufactured by
PANalytical Corporation
Tube: CuKa
Incidence angle: 0.50
Measurement range: 10-120°
[0079]
Measurement conditions for the XPS are the same as
those for the fluorine concentration.
[0080]
Firstly, a cross-section observation by the TEM was
carried out. A diffraction pattern was determined by
referring to data base (TiOF2: ICDD No.00-008-0060,
titanium a-phase: ICDD No.00-044-1294) provided by
International Centre for Diffraction Data, ICDD. As a
result of the observation, a diffraction pattern assigned
to TiOF2 (the crystal phase 2) was obtained in the first
region 12, and a diffraction pattern of titanium c-phase
(the second phase 32) was obtained in the second region
in both Examples 1 and 2.
[0081]
The first phase 31 was observed in the first region
12 in both Examples 1 and 2. A larger number of the
crystal phase 2 than the first phase 31 were observed in
Example 1. A larger number of the first phases 31 than
the crystal phase 2 were observed in Example 2. The
amorphous phase 4 and the mixed phase 5 were observed in
the first region 12 in Example 1.
[0082]
Then, measurement by the XRD was carried out. A
diffraction pattern was determined by referring to the
JCPDS provided by ICDD. As a result of the measurement,
a crystal structure different from that of the second
region was observed in the first region 12.
[0083]
Subsequently, measurement by the XPS was carried out. Peak assignment is presented in Table 1. As a result of the measurement, peaks assigned to TiF3, TiF4 and F-TiO2 were obtained in both Examples 1 and 2.
Although a peak assigned to Ti-F-Ti bonding was obtained,
the peak seems to be caused by a crystal of titanium
fluoride. In other respect, states illustrated in FIG. 1
were confirmed.
[0084]
C14 a)
C0 0 a
0C
4i
0
C..J4
C 1 . CJ C -4 CD C' ('~C)m 4J a') C, -r-.l) -CV) C c E -0 - 9 c'4 = 0.0a) < 0
Ca -C. 40 >0 0 > o
0U5 0 4)J- w 0 (U/ (
CC (U (tU (0 4) 4 )J _
4) -'4-0
0o E ~ E :3 E -0
m .9 co5 U2cC 0L) (D 2 L I 4) i C L d -:L C _ pc ' R 0
(U L
-l) cC% m'~ m
:3,0 0.0
r129
[0085]
(Antibacterial Activity)
Antibacterial activity was measured by a film
adhesion test using staph aureus (according to JIS Z
2801).
[0086]
Measurements results were as follows.
Attached viable cell count (CFUs)
Example 1: <10 (detection limit or less)
Comparative Example 1: 17667
[0087]
As a result of the measurement, the attached viable
cell count was the detection limit or less in Example 1.
Antibacterial activity value of Example 1 was 3.2.
Consequently, it became apparent that Example 1 had
antibacterial effect.
DESCRIPTION OF THE REFERENCE NUMERAL
[0088]
1 composite material
2 crystal phase of titanium fluoride
3 metal crystal phase of titanium
31 first phase
32 second phase
4 amorphous phase
5 mixed phase
11 surface
12 first region
12a midportion
T thickness
A thickness direction
13 second region
100 dental implant
101 fixture
102 abutment
103 artificial tooth

Claims (19)

CLAIMS:
1. A composite material, comprising: a crystal phase of titanium fluoride; an amorphous phase comprising titanium and fluorine; and a metal crystal phase of titanium, the crystal phase of the titanium fluoride being present in a first region located away from a surface in a depth direction.
2. The composite material according to claim 1, wherein the titanium fluoride is TiOF2.
3. The composite material according to claim 1 or claim 2, wherein the metal crystal phase comprises a first phase comprising fluorine.
4. The composite material according to claim 3, wherein the first phase is located in the first region.
5. The composite material according to claim 3 or claim 4, wherein: the metal crystal phase further comprises a second phase located more inside than the first phase, and the second phase comprises no fluorine.
6. The composite material according to claim 5, wherein the second phase is located more inside than the first region.
7. The composite material according to any one of claims I to 6, further comprising: a mixed phase comprising: the amorphous phase, the crystal phase of the titanium fluoride, and the metal crystal phase.
8. The composite material according to any one of claims 1 to 7, wherein a fluorine concentration reaches a maximum value at a portion located more inside than the surface.
9. The composite material according to claim 8, wherein the fluorine concentration increases to the maximum value when going from the surface toward inside.
10. The composite material according to claim 8 or claim 9, wherein the fluorine concentration reaches the maximum value in the first region.
11. The composite material according to claim 10, wherein the fluorine concentration reaches the maximum value at a side closer to the surface than a midportion in a depth direction of the first region.
12. The composite material according to any one of claims 1 to 11, wherein hardness reaches a maximum value at a portion located more inside than the surface.
13. The composite material according to claim 12, wherein the hardness increases to the maximum value when going from the surface toward inside.
14. The composite material according to claim 12 or claim 13, wherein the hardness reaches the maximum value in the first region.
15. The composite material according to claim 14, wherein the hardness reaches the maximum value at a side closer to the surface than a midportion in a depth direction of the first region.
16. The composite material according to any one of claims I to 15, wherein hardness reaches a maximum value at a side closer to the surface than a position at which a fluorine concentration reaches a maximum value.
17. The composite material according to any one of claims 1 to 16, the composite material being intended for a bioimplant.
18. A bioimplant comprising the composite material according to any one of claims I to 17.
19. The bioimplant of claim 18, wherein the implant is: a dental implant, an artificial joint, or a spine surgery implant.
AU2019279208A 2018-06-01 2019-05-30 Composite material and bioimplant Active AU2019279208B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2018-106267 2018-06-01
JP2018106267 2018-06-01
PCT/JP2019/021484 WO2019230871A1 (en) 2018-06-01 2019-05-30 Composite material and bioimplant

Publications (2)

Publication Number Publication Date
AU2019279208A1 AU2019279208A1 (en) 2021-01-28
AU2019279208B2 true AU2019279208B2 (en) 2022-01-27

Family

ID=68698885

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2019279208A Active AU2019279208B2 (en) 2018-06-01 2019-05-30 Composite material and bioimplant

Country Status (6)

Country Link
US (1) US20210196862A1 (en)
EP (1) EP3804768A4 (en)
JP (3) JP7155259B2 (en)
CN (1) CN112188903A (en)
AU (1) AU2019279208B2 (en)
WO (1) WO2019230871A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116600767A (en) * 2020-12-15 2023-08-15 京瓷株式会社 Composite material, method for producing same, and bioimplant

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005533551A (en) * 2002-07-19 2005-11-10 アストラ・テック・アクチエボラーグ Methods for treating implants and implant surfaces
JP2017101275A (en) * 2015-12-01 2017-06-08 京セラメディカル株式会社 Titanium material and living body implant

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19628459A1 (en) * 1996-07-15 1998-01-29 Siemens Ag Semiconductor device with low contact resistance to highly doped areas
JP4568396B2 (en) 2000-03-01 2010-10-27 株式会社イオンテクノセンター Surface treatment method of metal material and fluorination mold
JP2002332569A (en) * 2001-05-11 2002-11-22 Ion Engineering Research Institute Corp SURFACE MODIFYING METHOD FOR IMPARTING HIGH TEMPERATURE OXIDATION RESISTANCE TO Ti-Al BASED ALLOY
JP2004000504A (en) 2002-04-09 2004-01-08 Techno Network Shikoku Co Ltd Intraoral appliance and ion implantation method to intraoral appliance
DE102009027019B4 (en) * 2009-05-13 2011-01-05 Manfred Renkel Implant of intermetallic titanium-aluminide alloys
CN107773782A (en) 2016-08-24 2018-03-09 上海双申医疗器械股份有限公司 It is a kind of to put forward high purity titanium and the method for titanium alloy surface cytocompatibility and biocidal property
CN106637121B (en) * 2016-10-19 2019-04-12 中国科学院上海硅酸盐研究所慈溪生物材料表面工程中心 A kind of medical titanium metal alkyl materials and its manufacturing method

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005533551A (en) * 2002-07-19 2005-11-10 アストラ・テック・アクチエボラーグ Methods for treating implants and implant surfaces
JP2017101275A (en) * 2015-12-01 2017-06-08 京セラメディカル株式会社 Titanium material and living body implant

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
YOSHINARI, M. et al., "Influence of surface modifications to titanuim on antibacterial activity in vitro", Biomaterials, (2001), vol. 22, doi:10.1016/S0142-9612(00)00392-6, pages 2043 - 2048 *

Also Published As

Publication number Publication date
JPWO2019230871A1 (en) 2021-06-17
CN112188903A (en) 2021-01-05
EP3804768A9 (en) 2022-08-31
AU2019279208A1 (en) 2021-01-28
JP2024028859A (en) 2024-03-05
US20210196862A1 (en) 2021-07-01
JP7155259B2 (en) 2022-10-18
JP7400049B2 (en) 2023-12-18
JP2023015032A (en) 2023-01-31
EP3804768A1 (en) 2021-04-14
WO2019230871A1 (en) 2019-12-05
EP3804768A4 (en) 2022-03-09

Similar Documents

Publication Publication Date Title
Wang et al. In vitro and in vivo studies on Ti-based bulk metallic glass as potential dental implant material
Lausmaa Surface spectroscopic characterization of titanium implant materials
US20130302512A1 (en) Methods for altering the surface chemistry of biomedical implants and related apparatus
JP2024028859A (en) Composite material and bioimplant
Çaha et al. A Review on Bio-functionalization of β-Ti Alloys
Masahashi et al. Study of bioactivity on a TiNbSn alloy surface
Zhang et al. Surface nanocrystallization and biomedical performance of Ti-Ta laminated composite processed by surface mechanical grinding treatment
Sun et al. Bioactive (Si, O, N)/(Ti, O, N)/Ti composite coating on NiTi shape memory alloy for enhanced wear and corrosion performance
Hong et al. Improved bonding strength between TiO2 film and Ti substrate by microarc oxidation
JP2007526777A (en) Method of manufacturing intraosseous implant or medical prosthesis by ion implantation, and intraosseous implant or medical prosthesis manufactured thereby
Das et al. Pulsed laser-deposited hopeite coatings on titanium alloy for orthopaedic implant applications: surface characterization, antibacterial and bioactivity studies
Izman et al. Effect of pretreatment process on thermal oxidation of biomedical grade cobalt based alloy
EP3195825B1 (en) Dental implant
Schmitz Functional coatings by physical vapor deposition (PVD) for biomedical applications
WO2022130981A1 (en) Composite material, method for manufacturing same, and biological implant
US20220226548A1 (en) Metal material having biological properties
RU2554773C1 (en) Material for bactericidal coating
KR102010467B1 (en) Metal biomaterial and method for manufacturing the same
Adeniyi The Microstructure and Properties of Niobium-doped Diamond-like Carbon Thin films
de Viteri et al. Tribocorrosion and antibacterial behaviour of TiO 2 coatings obtained by PEO technique
SALEEM DEPOSITION OF BIOCOMPATIBLE THIN FILMS USING GLOW DISCHARGE
Ali Application of zirconium-coated titanium wires as restorative orthodontic materials
JP2021062099A (en) Biomaterial and manufacturing method of biomaterial
ÜNLÜ ĐSTANBUL TECHNICAL UNIVERSITY★ INSTITUTE OF SCIENCE AND TECHNOLOGY
Rafieerad et al. Author's Accepted Manuscript

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)